Pfizer has asked a U.S. court to throw out a lawsuit brought by a whistleblower that revealed problems at the testing sites used in Pfizer’s critical phase III trial of its COVID-19 vaccine.
Brook Jackson, the whistleblower, filed a False Claims Act lawsuit against Pfizer, Ventavia, and ICON, alleging they had “concealed violations of both their clinical trial protocol and federal regulations, including falsification of clinical trial documents.”
But Pfizer, in its motion to dismiss the case, argued that such regulations don’t apply to its vaccine contract with the U.S. Department of Defense because the agreement was conducted under the auspices of an Other Transaction Agreement (OTA), reported The Epoch Times’ Zachary Stieber. An OTA allows contractors to circumvent otherwise existing rules and laws that typically apply to contracts. Pfizer was granted its contract to develop a “prototype,” which falls under the protection of an OTA.
Read more at Newsmax© 2022 Newsmax. All rights reserved.